Stock Events

Stock Events

China SXT Pharmaceuticals 

$1.81
24
+$0+0.28% Today

Statistics

Day High
1.88
Day Low
1.62
52W High
1,047
52W Low
1.25
Volume
12,844
Avg. Volume
312,227
Mkt Cap
24.84M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

18JulExpected
Q3 2019
Q1 2020
Q2 2020
Q4 2020
Q2 2021
Q4 2021
Q2 2022
-2.03
-1.32
-0.61
0.1
Expected EPS
0
Actual EPS
-2.03

Financials

-189.78%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
3.48MRevenue
-6.61MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SXTC. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
111
YI
Mkt Cap37.76M
111, Inc. operates a leading direct-to-patient digital healthcare platform in China, offering similar pharmaceutical products and services, thus competing in the same market space.
Zai Lab Limited
ZLAB
Mkt Cap2.91B
Zai Lab Limited is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines in China, directly competing in the pharmaceutical innovation and distribution sector.
HUTCHMED (China) Limited
HCM
Mkt Cap2.52B
Hutchison China MediTech Limited engages in the research, development, and commercialization of therapies in oncology and autoimmune diseases, competing for market share in China's pharmaceutical sector.
Sinovac Biotech
SVA
Mkt Cap642.44M
Sinovac Biotech Ltd. specializes in the research, development, manufacturing, and commercialization of vaccines, competing in the healthcare and pharmaceutical market in China.
Can-Fite Biopharma
CANF
Mkt Cap15.35M
Can-Fite BioPharma Ltd. is an advanced clinical stage drug development company with a platform aimed at addressing cancer, liver, and inflammatory diseases, competing in the pharmaceutical market.
Novartis
NVS
Mkt Cap237.61B
Novartis AG, a multinational pharmaceutical company, offers a broad range of healthcare products that compete in the Chinese market, including innovative medicines and generics.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc., a global biopharmaceutical company, competes in China through its wide range of healthcare products, including vaccines, oncology, and internal medicine.

About

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.
Show more...
CEO
Mr. Feng Zhou
Employees
75
Country
VG
ISIN
VGG2161P1650

Listings

XNAS
US
SXTC
BOATS
BOATS
SXTC.BOATS
F
DE
2RY1.F

0 Comments

Share your thoughts

FAQ

What is China SXT Pharmaceuticals stock price today?▼
The current price of SXTC is $1.81 USD — it has increased by +0.28% in the past 24 hours. Watch China SXT Pharmaceuticals stock price performance more closely on the chart.
What is China SXT Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange China SXT Pharmaceuticals stocks are traded under the ticker SXTC.
Is China SXT Pharmaceuticals stock price growing?▼
SXTC stock has risen by +36.36% compared to the previous week, the month change is a -19.64% fall, over the last year China SXT Pharmaceuticals has showed a -99.53% decrease.
What is China SXT Pharmaceuticals market cap?▼
Today China SXT Pharmaceuticals has the market capitalization of 24.84M
What were China SXT Pharmaceuticals earnings last quarter?▼
SXTC earnings for the last quarter are -2.03 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is China SXT Pharmaceuticals revenue for the last year?▼
China SXT Pharmaceuticals revenue for the last year amounts to 3.48M USD.
What is China SXT Pharmaceuticals net income for the last year?▼
SXTC net income for the last year is -6.61M USD.
How many employees does China SXT Pharmaceuticals have?▼
As of April 02, 2026, the company has 75 employees.
In which sector is China SXT Pharmaceuticals located?▼
China SXT Pharmaceuticals operates in the Consumer Staples sector.
When did China SXT Pharmaceuticals complete a stock split?▼
The last stock split for China SXT Pharmaceuticals was on February 03, 2026 with a ratio of 1:150.
Where is China SXT Pharmaceuticals headquartered?▼
China SXT Pharmaceuticals is headquartered in Taizhou, VG.